Honluten

1 Identity

Trade name of a finished oral capsule declaring a peptide complex of undeclared sequence. Not a chemical entity as sold. of which 'Honluten' and 'Chonluten' are two transliterations of one name. The article as sold declares 'peptide complex AC-7'. Bronchogen, reported in the program literature as the tetrapeptide Ala-Glu-Asp-Leu, is not a synonym for any of those names but a different molecule, and the distinction is load-bearing.

Sequence

No defined sequence. Honluten and Chonluten are not two articles; they are two transliterations of one Russian trade name, Хонлутен. A retailer lists 'Honluten' explicitly as the alternative spelling of its Chonluten product, and the two names carry an identical declared composition wherever it is published: 'peptide complex AC-7 (glycine, glutamic acid, aspartic acid)', 200 mg per capsule, with microcrystalline cellulose, beetroot sugar, lactose, starch and Tween-80 as excipients. The AC- prefix marks the manufacturer's synthesized (Cytogen) line, not the tissue-extract (Cytomax) line that carries A- numbers. What the label declares is a set of three constituent amino acids, not an order and not a stoichiometry: Gly, Glu and Asp are consistent with the tripeptide Glu-Asp-Gly (C11H17N3O8, 319.27 average / 319.1016 monoisotopic) but the declaration does not establish sequence, and every permutation of those three residues has the identical formula and the identical mass. No formula can be assigned to the article as sold.

Molecular formula

Not established for the article as sold. If a supplier declares Glu-Asp-Gly in writing, the formula becomes C11H17N3O8 and the record is rebuilt on panel P1. Until that declaration exists in writing, no formula belongs in this field.

Average mass

Not established, and no number is printed here. The declared composition is an amino acid set with no stated order and no stated stoichiometry, and the article in commerce is a 200 mg capsule of which the peptide fraction is one component. If a supplier declares Glu-Asp-Gly in writing, the record becomes 319.27 Da average and 319.1016 Da monoisotopic on panel P1, both following from that formula. That is a statement about what a declaration would produce, not a mass for this article.

Monoisotopic mass

Not established. See the average mass entry above. A mass cannot be assigned to a preparation whose composition is declared as three constituent amino acids with no order and no stoichiometry, and the permutation problem means that even a correct mass would not establish which molecule is present.

Salt / variant note

Honluten and Chonluten are two transliterations of one Russian trade name, so the first variant question on any order is which article the supplier means. The label declares a set of three amino acids and no order, so the name alone does not fix the molecule. Beyond that, the defined molecules a supplier would ship against a Honluten order are: Glu-Asp-Gly, C11H17N3O8, 319.27 / 319.1016 - the sequence the AC-7 amino acid set is usually read as, and note that Gly-Asp-Glu, Asp-Glu-Gly and every other permutation of those three residues has the identical formula and identical mass, so a mass alone never establishes the order and only MS/MS fragment ordering or co-elution with a sequenced standard does. Bronchogen (Ala-Glu-Asp-Leu), C18H30N4O9, 446.46 / 446.2013 - the article the phrase 'a synthetic 4-amino-acid lung bioregulator' actually fits, and a figure that sits about 16 mDa from this catalog's Ovagen record at 446.217 monoisotopic, so at nominal or unit resolution two catalog records are indistinguishable from each other. Epitalon (Ala-Glu-Asp-Gly), C14H22N4O9, 390.35 / 390.1387, the family's default filler. Vesugen (Lys-Glu-Asp), C15H26N4O8, 390.39 / 390.1751, which sits 0.0364 Da - about 93 ppm at m/z 390 - from Epitalon. And a fifth article that is not a capsule at all: 'Honluten Peptide' is now sold as a lyophilized research vial in 5, 10, 15, 20, 30, 40 and 60 mg sizes with a claimed purity of at least 99 percent and 'COA verified' printed on the page, and with no sequence, no molecular formula and no molecular weight published anywhere on the listing.

2 Class & testing panel

Form

Single article

Testing panel

P7 — panel definition

3 Primary sources & evidence

The index reports the design and provenance of the literature, not a conclusion about effect.

No PubMed-indexed primary literature identifies a compound named Honluten; the name returns vendor material only. The adjacent short synthetic peptides in the same program - Chonluten under its defined tripeptide description, and Bronchogen - have their own small, mostly Russian-language in-vitro and rodent literature, but that literature concerns defined molecules and cannot be transferred to a preparation whose composition is declared as three amino acids with no order. Doing so is the single most common failure in this product category, and the citation index for this record says so explicitly rather than listing borrowed references. No controlled human trial of this preparation was identified, and no registered trial was found. There is a second reason the borrowing fails here beyond the general one: because Honluten and Chonluten are one trade name, any citation offered for either would have to be checked against which molecule the study actually used, and the published record does not permit that check.

4 Storage & specification

Storage

No commercial article is accepted into inventory and no storage condition is labeled. Any sample obtained solely for the identity investigation is held at -20 degrees C plus or minus 5 degrees C, desiccated, in its original sealed container, quarantined, physically segregated from sellable stock, and flagged non-fillable in the inventory system. It is not counted as inventory and carries no value on the balance sheet. Where a supplier's answer to the written composition question is that the article is tissue-derived, any such sample is additionally handled under the site's animal-tissue segregation rule and is not stored in the same cabinet as synthetic articles.

Shelf life

No retest interval is assigned, because no article is stocked.